This review article examines how BPC 157, a synthetic peptide derived from gastric juice, may provide cytoprotective effects that could theoretically address both hemorrhagic and thrombotic conditions through a unified mechanism (evidence level: review of human clinical, animal model, and in vitro studies). The authors synthesize existing literature suggesting BPC 157 promotes cellular protective mechanisms and vascular homeostasis, though the specific pathways and clinical applicability remain largely supported by preclinical evidence rather than robust human trials. The review highlights the potential therapeutic relevance of cytoprotective strategies but does not establish definitive clinical efficacy in human hemorrhage or thrombosis management.